Riccardi Maria Teresa, Heidar Alizadeh Aurora, Costigliolo Bianca Maria, Nisticò Anna, Olivo Lia, Nurchis Mario Cesare, Maurici Massimo, Graps Elisabetta Anna, Oddone Trinito Massimo, Damiani Gianfranco
Local Health Unit Roma 2, 00159 Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.
Healthcare (Basel). 2025 May 16;13(10):1161. doi: 10.3390/healthcare13101161.
: Colorectal (CRC), breast (BC), and cervical cancer (CC) pose a significant health burden, yet screening programs have been proven to reduce cancer-specific mortality and other non-lethal endpoints. Mobile health (mHealth) technologies can enhance adherence, but effectiveness varies. This scoping review aims to explore mHealth apps for cancer screening developed with community engagement, identifying research approaches and gaps. : A scoping review following PRISMA-ScR guidelines analyzed studies on mHealth apps for cancer screening developed through community engagement. Community engagement was classified per WHO's definition. Databases were searched using a PCC-based strategy; eligible studies involved app development, excluding hypothetical apps or text messaging-/social media-only interventions. Screening and data extraction were conducted independently. : Thirteen articles were included. Findings indicate a growing but limited body of evidence, with most studies focusing on CRC and BC and involving minority populations through mHealth apps. Key engagement phases included research design, CAB establishment, and recruitment, while priority setting was never community-led. The wMammogram, Meet ALEX, and mMammogram apps improved screening knowledge, intention, and participation, while ColorApp enhanced knowledge but not attitudes. Only CBPR-based studies included dissemination, and one involved the CAB in data analysis. Some studies acknowledged community contributions, though details on ColorApp's engagement were limited. : Standardized engagement frameworks combined with mHealth were associated with greater community involvement and may improve equity. No community-designed mHealth app was found for CC screening, despite its relevance. Future research should address gaps in CC programs, prioritize early community involvement, and assess the long-term impact of mHealth interventions.
结直肠癌（CRC）、乳腺癌（BC）和宫颈癌（CC）造成了巨大的健康负担，但筛查项目已被证明可降低癌症特异性死亡率及其他非致命性终点事件。移动健康（mHealth）技术可提高依从性，但其有效性存在差异。本综述旨在探索通过社区参与开发的用于癌症筛查的mHealth应用程序，确定研究方法和差距。
一项遵循PRISMA-ScR指南的综述分析了通过社区参与开发的用于癌症筛查的mHealth应用程序的研究。社区参与根据世界卫生组织的定义进行分类。使用基于PCC的策略搜索数据库；符合条件的研究涉及应用程序开发，不包括假设性应用程序或仅通过短信/社交媒体进行的干预措施。筛选和数据提取独立进行。
纳入了13篇文章。研究结果表明，证据数量在不断增加，但仍然有限，大多数研究聚焦于结直肠癌和乳腺癌，且通过mHealth应用程序涉及少数族裔人群。关键参与阶段包括研究设计、建立社区咨询委员会（CAB）和招募，而优先级设定从未由社区主导。wMammogram、Meet ALEX和mMammogram应用程序提高了筛查知识、意愿和参与度，而ColorApp增强了知识，但未改善态度。只有基于社区参与的行动研究（CBPR）的研究包括传播，且有一项研究让社区咨询委员会参与数据分析。一些研究认可了社区贡献，尽管关于ColorApp参与情况的细节有限。
标准化的参与框架与mHealth相结合与更大程度的社区参与相关，可能会改善公平性。尽管宫颈癌筛查具有相关性，但未发现社区设计的用于宫颈癌筛查的mHealth应用程序。未来的研究应解决宫颈癌筛查项目中的差距，优先让社区早期参与，并评估mHealth干预措施的长期影响。
